Glowing dye helps surgeons remove stomach cancer while saving healthy tissue
NCT ID NCT06788548
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new surgical approach for early gastric cancer that uses a fluorescent dye to help surgeons see and remove only the cancerous lymph nodes, sparing healthy tissue. About 312 patients will be randomly assigned to either this new technique or standard surgery. The goal is to see if the new method can control the cancer as well as standard surgery while preserving more stomach function and improving quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fluorescence-guided surgery procedure
What this could lead to
If successful, this approach could offer a less invasive surgical option for early gastric cancer, preserving more of the stomach and improving quality of life while maintaining cancer control.
What could go wrong
This is a relatively early-stage trial with 312 participants, and the technique may not prove as effective as standard surgery in preventing cancer return. There are also risks from the surgery itself, such as infection or complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Friendship Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100050, China
Contact Phone: •••-•••-•••• Email: •••••@•••••